Hypertension Notes - Medicine 3rd Year
1. Definition
Hypertension (HTN) is a persistent elevation of systemic arterial blood pressure sufficient to increase cardiovascular, cerebrovascular, renal, and retinal morbidity and mortality.
- Usually asymptomatic.
- Major modifiable risk factor for stroke, myocardial infarction, heart failure, chronic kidney disease, atrial fibrillation, peripheral arterial disease, and vascular dementia.
- Most cases are primary (essential) hypertension.
- A minority have an identifiable cause: secondary hypertension.
Accurate diagnosis requires repeated, reproducible BP readings and preferably confirmation by home BP monitoring (HBPM) or ambulatory BP monitoring (ABPM). Katzung's Basic and Clinical Pharmacology, 16th ed., p. 268.
2. Classification of Blood Pressure
A. ACC/AHA classification
| Category | Systolic BP (mmHg) | Diastolic BP (mmHg) |
|---|
| Normal | <120 | and <80 |
| Elevated | 120-129 | and <80 |
| Stage 1 hypertension | 130-139 | or 80-89 |
| Stage 2 hypertension | ≥140 | or ≥90 |
| Hypertensive crisis | >180 | and/or >120 |
B. Traditional / ESC-ESH clinical classification
| Category | BP |
|---|
| Optimal | <120/80 mmHg |
| Normal | 120-129/80-84 mmHg |
| High normal | 130-139/85-89 mmHg |
| Grade 1 HTN | 140-159/90-99 mmHg |
| Grade 2 HTN | 160-179/100-109 mmHg |
| Grade 3 HTN | ≥180/≥110 mmHg |
| Isolated systolic HTN | ≥140/<90 mmHg |
Exam point: Diagnostic thresholds differ between guideline systems. The 2024 ESC guideline retains office BP
≥140/90 mmHg as the definition of hypertension, while the ACC/AHA system labels BP ≥130/80 mmHg as hypertension. Out-of-office readings help confirm diagnosis and identify white-coat or masked hypertension.
ESC 2024 guideline summary
3. Types of Hypertension
A. Primary or essential hypertension
- About 90%-95% of cases.
- No single identifiable cause.
- Multifactorial: genetic predisposition plus environmental influences.
Important contributors
- Family history
- Aging
- Obesity and insulin resistance
- High salt intake
- Low dietary potassium
- Alcohol excess
- Physical inactivity
- Smoking
- Psychosocial stress
- Obstructive sleep apnea
- Chronic kidney disease
B. Secondary hypertension
- Around 5%-10% of patients.
- Has a specific, potentially treatable cause.
- Suspect when hypertension is abrupt, severe, early-onset, resistant, or associated with clues such as hypokalemia, proteinuria, or disproportionate target-organ damage.
4. Pathophysiology of Essential Hypertension
Blood pressure:
[
\text{BP} = \text{Cardiac Output} \times \text{Systemic Vascular Resistance}
]
Hypertension develops through an interplay of the following mechanisms:
A. Increased sympathetic nervous system activity
- Raises heart rate, cardiac output, and peripheral vascular resistance.
- Prominent in stress, obesity, sleep apnea, and early hypertension.
B. Renin-angiotensin-aldosterone system activation
- Renin converts angiotensinogen to angiotensin I.
- ACE converts angiotensin I to angiotensin II.
- Angiotensin II causes vasoconstriction and stimulates aldosterone.
- Aldosterone increases sodium and water retention.
C. Renal sodium retention
- Impaired renal sodium excretion raises extracellular fluid volume.
- This elevates cardiac output initially, followed by increased peripheral resistance.
D. Endothelial dysfunction
- Reduced nitric oxide-mediated vasodilation.
- Increased endothelin and oxidative stress.
- Promotes vasoconstriction and vascular inflammation.
E. Vascular remodeling
- Persistent pressure causes medial hypertrophy and narrowing of arterioles.
- Increases systemic vascular resistance.
- Leads to a self-perpetuating cycle of hypertension.
F. Arterial stiffness
- Especially important in elderly individuals.
- Causes increased systolic BP and widened pulse pressure.
- Leads to isolated systolic hypertension.
5. Clinical Features
Most patients are asymptomatic.
Possible nonspecific symptoms:
- Occipital headache, especially early morning
- Dizziness
- Palpitations
- Fatigue
- Blurring of vision
- Epistaxis
These are not reliable indicators of hypertension severity.
Symptoms suggesting target-organ damage
- Chest pain: acute coronary syndrome, aortic dissection
- Dyspnea: left ventricular failure or pulmonary edema
- Neurologic deficit: stroke
- Confusion, headache, seizures, visual disturbance: hypertensive encephalopathy
- Reduced urine output or hematuria: renal injury
- Sudden visual loss: severe hypertensive retinopathy
The initial assessment should establish BP accurately, assess total cardiovascular risk, search for target-organ injury, and identify patients needing evaluation for secondary causes. Goldman-Cecil Medicine, 2-volume set, p. 743.
6. Correct Blood Pressure Measurement
This is a frequent exam question.
Preparation
- No smoking, caffeine, or exercise for at least 30 minutes.
- Empty bladder.
- Quiet environment.
- Patient seated and resting for at least 5 minutes.
- Back supported, feet flat on floor, legs uncrossed.
- Arm supported at heart level.
- Use a validated, calibrated device.
- Correct cuff size:
- Bladder length: about 75%-100% of arm circumference
- Bladder width: about 37%-50% of arm circumference
Technique
- Measure BP in both arms at the first visit.
- Use the arm with the higher value for later measurements.
- Take at least two readings, 1-2 minutes apart.
- Average the readings.
- Repeat on separate visits unless BP is severely elevated or there is acute target-organ damage.
- Measure standing BP, especially in elderly people, diabetes, autonomic dysfunction, or symptoms of postural hypotension.
Korotkoff sounds
- Phase I: first tapping sound = systolic BP
- Phase V: disappearance of sounds = diastolic BP
White-coat hypertension
- High clinic BP but normal home/ambulatory BP.
- Increased future risk of sustained hypertension.
- Usually observe, assess cardiovascular risk, and emphasize lifestyle measures.
Masked hypertension
- Normal clinic BP but elevated out-of-office BP.
- Higher cardiovascular risk than normotension.
- Common in diabetes, chronic kidney disease, smokers, and patients with sleep apnea.
7. Evaluation of a Patient With Hypertension
A. Objectives
- Confirm persistent hypertension.
- Assess total cardiovascular risk.
- Look for hypertension-mediated organ damage.
- Identify secondary hypertension.
- Identify contributing lifestyle factors and medicines.
- Select appropriate treatment.
B. History
Risk factors
- Family history of hypertension, premature cardiovascular disease, or stroke
- Diabetes, dyslipidemia, chronic kidney disease
- Smoking
- Obesity
- High salt intake
- Alcohol
- Sedentary lifestyle
- Sleep apnea symptoms: snoring, witnessed apneas, daytime sleepiness
Symptoms of target-organ damage
- Angina, dyspnea, orthopnea, paroxysmal nocturnal dyspnea
- Palpitations
- Transient ischemic attack or stroke symptoms
- Headache, seizures, visual symptoms
- Claudication
- Nocturia, edema, reduced urine output
Drug history
Ask specifically about:
- NSAIDs
- Oral contraceptive pills
- Corticosteroids
- Decongestants and sympathomimetics
- Cocaine, amphetamines
- Cyclosporine, tacrolimus
- Erythropoietin
- Herbal drugs, especially liquorice
- Alcohol
C. Examination
General
- BMI and waist circumference
- Pulse rate and rhythm
- Signs of Cushing syndrome or thyroid disease
- Features of acromegaly
- Neurocutaneous signs of neurofibromatosis
BP assessment
- Both arms
- Standing BP for postural drop
- Consider lower-limb BP if coarctation is suspected
Cardiovascular system
- Displaced apex beat, LV heave
- S4 gallop
- Murmurs
- Signs of heart failure
- Peripheral pulses and bruits
Abdomen
- Renal masses
- Abdominal bruit suggesting renal artery stenosis
Fundus examination
Hypertensive retinopathy:
- Arteriolar narrowing
- Arteriovenous nicking
- Hemorrhages, cotton-wool spots, hard exudates
- Papilledema in malignant hypertension
Hypertensive retinopathy may be an early physical sign, while ECG/cardiac enlargement and rising creatinine can precede severe organ damage. Goldman-Cecil Medicine, 2-volume set, p. 742.
8. Investigations
A. Routine investigations
| Test | Purpose |
|---|
| Urinalysis | Proteinuria, hematuria, renal disease |
| Urine albumin-creatinine ratio | Detect albuminuria |
| Serum creatinine and eGFR | Renal function |
| Serum sodium, potassium, bicarbonate, calcium | Renal/endocrine causes; baseline before drugs |
| Fasting glucose or HbA1c | Diabetes screening |
| Lipid profile | Cardiovascular risk |
| Complete blood count | Baseline and secondary causes |
| ECG | LVH, ischemia, arrhythmia |
| Fundus examination | Retinopathy |
| Echocardiography, if indicated | LVH, systolic/diastolic dysfunction |
A standard work-up includes blood counts, glucose/HbA1c, creatinine/eGFR, electrolytes, lipid profile, urinalysis, urine albumin-creatinine ratio, and ECG. Goldman-Cecil Medicine, 2-volume set, p. 743.
B. Tests for secondary causes, when indicated
| Suspected cause | Initial tests |
|---|
| Primary aldosteronism | Plasma aldosterone-renin ratio, serum potassium |
| Renal parenchymal disease | Urinalysis, creatinine/eGFR, renal ultrasound |
| Renovascular HTN | Doppler renal arteries, CT/MR angiography |
| Pheochromocytoma | Plasma free metanephrines or urinary fractionated metanephrines |
| Cushing syndrome | Overnight dexamethasone suppression test or urinary free cortisol |
| Thyroid disease | TSH, free T4 |
| Obstructive sleep apnea | Sleep study |
| Coarctation of aorta | Arm-leg BP difference, echocardiography/CT angiography |
9. Hypertension-Mediated Organ Damage
Heart
- Left ventricular hypertrophy
- Ischemic heart disease
- Heart failure, initially HFpEF and later HFrEF
- Atrial fibrillation
- Sudden cardiac death
Brain
- TIA
- Ischemic stroke
- Intracerebral hemorrhage
- Vascular cognitive impairment/dementia
- Hypertensive encephalopathy
Kidneys
- Albuminuria/proteinuria
- Hypertensive nephrosclerosis
- Progressive CKD
- End-stage kidney disease
Eyes
- Hypertensive retinopathy
- Retinal hemorrhages/exudates
- Papilledema in malignant hypertension
Blood vessels
- Aortic aneurysm/dissection
- Peripheral arterial disease
- Carotid artery disease
10. Secondary Hypertension
When should you suspect it?
Suspect secondary hypertension in:
- Onset before age 30 years, especially if no family history or obesity
- Abrupt onset or sudden worsening
- Severe hypertension
- Resistant hypertension
- Recurrent hypertensive emergencies
- Unprovoked hypokalemia
- Proteinuria or renal dysfunction
- Abdominal bruit
- Episodic headache, sweating, and palpitations
- Clinical features of endocrine disease
- Disproportionate target-organ damage
Secondary hypertension should be considered in resistant hypertension, abrupt worsening, disproportionate target-organ injury, or findings such as unexplained hypokalemia, proteinuria, and LVH. Harrison's Principles of Internal Medicine, 22nd ed., chapter 288.
Important causes
A. Renal causes
-
Renal parenchymal disease
- CKD, chronic glomerulonephritis, polycystic kidney disease
- Most common secondary cause overall
-
Renovascular hypertension
- Atherosclerotic renal artery stenosis in older patients
- Fibromuscular dysplasia in young women
- Clues: abdominal bruit, recurrent flash pulmonary edema, abrupt rise in creatinine after ACE inhibitor/ARB
B. Endocrine causes
-
Primary aldosteronism
- Resistant HTN, hypokalemia, metabolic alkalosis
- High aldosterone-renin ratio
-
Pheochromocytoma
- Episodic headache, sweating, palpitations
- Paroxysmal or labile hypertension
- Test metanephrines
-
Cushing syndrome
- Central obesity, moon face, striae, diabetes, proximal myopathy
-
Thyroid disease
- Hyperthyroidism: mainly systolic HTN
- Hypothyroidism: mainly diastolic HTN
-
Acromegaly
- Enlarged hands/feet, coarse face, glucose intolerance
C. Other causes
- Obstructive sleep apnea
- Coarctation of aorta
- Pregnancy-associated hypertension
- Drugs and substances
In resistant hypertension, reconsider secondary causes particularly primary aldosteronism, renovascular disease, and obstructive sleep apnea. National Kidney Foundation Primer on Kidney Diseases, 8th ed.
11. Management of Hypertension
Treatment goals
Targets must be individualized according to age, frailty, symptoms, renal function, and comorbidities.
A commonly used target:
- <140/90 mmHg for most treated adults
- Often aim for <130/80 mmHg if tolerated in diabetes, CKD, established cardiovascular disease, or high cardiovascular risk
- Avoid excessive lowering in frail elderly patients or those with symptomatic postural hypotension.
The 2024 ESC recommendations generally aim for treated office systolic BP of
120-129 mmHg if tolerated, while individualizing targets for frailty and intolerance.
ESC guideline commentary
A. Lifestyle modification
Recommended for every patient, regardless of need for drugs.
| Intervention | Advice |
|---|
| Weight reduction | Aim for healthy BMI and waist circumference |
| Salt restriction | Reduce dietary sodium, avoid processed foods/pickles/papads |
| DASH-style diet | Fruits, vegetables, legumes, whole grains, low-fat dairy |
| Physical activity | At least 150 min/week moderate aerobic activity |
| Alcohol | Avoid or limit |
| Smoking | Complete cessation |
| Healthy sleep | Evaluate and treat sleep apnea |
| Stress management | Sleep, exercise, relaxation strategies |
DASH diet: Dietary Approaches to Stop Hypertension. High in fruits, vegetables, nuts, whole grains, low-fat dairy; low in saturated fat and sodium.
B. Drug therapy
First-line drug classes
-
Thiazide or thiazide-like diuretic
- Chlorthalidone, indapamide, hydrochlorothiazide
- Useful in elderly persons and salt-sensitive hypertension.
- Adverse effects: hypokalemia, hyponatremia, hyperuricemia, gout, glucose intolerance.
-
ACE inhibitor
- Enalapril, lisinopril, ramipril
- Particularly useful in CKD with albuminuria, diabetes with albuminuria, heart failure, and post-MI LV dysfunction.
- Adverse effects: dry cough, hyperkalemia, rise in creatinine, rare angioedema.
- Avoid in pregnancy and bilateral renal artery stenosis.
-
Angiotensin receptor blocker (ARB)
- Losartan, telmisartan, valsartan
- Alternative if ACE inhibitor cough occurs.
- Adverse effects: hyperkalemia and increased creatinine.
- Avoid in pregnancy and bilateral renal artery stenosis.
-
Calcium-channel blocker
- Dihydropyridines: amlodipine, nifedipine
- Good for isolated systolic HTN and elderly patients.
- Adverse effects: ankle edema, flushing, headache, gingival hyperplasia.
Important rule
Do not combine an ACE inhibitor with an ARB because of excess renal dysfunction and hyperkalemia.
C. Choosing initial treatment
Stage 1 / mild hypertension
- Lifestyle changes first in lower-risk patients.
- One drug may be suitable if BP is close to target.
Stage 2 hypertension or BP markedly above target
- Start two complementary drugs, preferably as a single-pill combination.
Preferred two-drug combinations
- ACE inhibitor or ARB + CCB
- ACE inhibitor or ARB + thiazide/thiazide-like diuretic
Effective combinations commonly pair an ACE inhibitor or ARB with either a calcium-channel blocker or a thiazide-like diuretic. Goldman-Cecil Medicine, 2-volume set.
Triple therapy
If BP remains uncontrolled:
- ACE inhibitor or ARB + CCB + thiazide-like diuretic
Resistant hypertension
Uncontrolled BP despite adherence to:
- Three appropriate drugs at adequate doses, including a diuretic, or
- Controlled BP requiring four or more agents.
Steps:
- Confirm adherence.
- Exclude white-coat effect using HBPM/ABPM.
- Identify high salt intake, alcohol excess, and BP-raising drugs.
- Check for secondary causes.
- Add spironolactone if potassium and renal function permit.
12. Drug Choice in Common Comorbidities
| Condition | Preferred drugs / principles |
|---|
| Diabetes with albuminuria | ACE inhibitor or ARB |
| CKD with proteinuria | ACE inhibitor or ARB, monitor creatinine and potassium |
| Heart failure with reduced EF | ACEi/ARB/ARNI, evidence-based beta-blocker, mineralocorticoid antagonist, diuretics as needed |
| Post-MI / coronary artery disease | Beta-blocker plus ACE inhibitor or ARB |
| Atrial fibrillation | Beta-blocker or non-dihydropyridine CCB for rate control if appropriate |
| Angina | Beta-blocker or CCB |
| Gout | Avoid or use thiazides cautiously; consider losartan if suitable |
| Asthma | Avoid nonselective beta-blockers |
| Pregnancy | Labetalol, nifedipine, methyldopa |
| BPH | Alpha-blocker may help urinary symptoms but is not first-line for HTN |
13. Hypertensive Crisis
A. Hypertensive urgency
- Severe BP elevation, usually ≥180/120 mmHg
- No acute target-organ damage
- Often called severe asymptomatic hypertension.
Management
- Do not rapidly lower BP.
- Recheck BP after rest and correct measurement.
- Reinstate/intensify oral medication.
- Assess adherence and precipitating factors.
- Close follow-up within days.
B. Hypertensive emergency
Definition: Severe BP elevation with acute or progressive target-organ damage.
Typical BP is ≥180/110 or ≥180/120 mmHg, but the diagnosis depends on acute organ injury, not BP alone.
Examples
- Hypertensive encephalopathy
- Intracerebral hemorrhage
- Acute ischemic stroke with special BP indications
- Acute pulmonary edema / acute LV failure
- Acute coronary syndrome
- Aortic dissection
- Acute kidney injury
- Eclampsia
- Malignant hypertension with papilledema
Hypertensive emergency requires immediate BP reduction using titratable IV drugs in a closely monitored critical-care setting. Goldman-Cecil Medicine, 2-volume set, p. 741.
General BP-lowering principle
- Reduce mean arterial pressure by no more than 20%-25% in the first hour.
- Then reduce to approximately 160/100-110 mmHg over the next 2-6 hours.
- Gradually normalize over the next 24-48 hours.
Why not lower BP rapidly? Chronic hypertension shifts cerebral, renal, and coronary autoregulation to higher pressure levels. Abrupt BP fall can cause cerebral ischemia, MI, or acute kidney injury.
Common IV drugs
| Situation | Common drug options |
|---|
| General hypertensive emergency | Nicardipine, clevidipine, labetalol |
| Acute pulmonary edema | Nitroglycerin, nitroprusside, loop diuretic |
| Aortic dissection | IV beta-blocker first, such as esmolol or labetalol; then vasodilator if necessary |
| Acute coronary syndrome | Nitroglycerin, beta-blocker if suitable |
| Pheochromocytoma crisis | Phentolamine |
| Eclampsia/severe preeclampsia | IV labetalol, hydralazine, or oral immediate-release nifedipine; magnesium sulfate for seizures |
| Acute ischemic stroke | Individualize according to thrombolysis/thrombectomy eligibility |
Aortic dissection exception: Lower systolic BP rapidly, often to <120 mmHg, while reducing heart rate promptly, because continued high shear stress can extend the dissection.
14. Malignant Hypertension
A severe form of hypertension characterized by:
- Markedly elevated BP
- Advanced bilateral hypertensive retinopathy
- Retinal hemorrhages, exudates, and papilledema
- Often acute renal impairment
- May cause encephalopathy, heart failure, or microangiopathic hemolytic anemia
It is a medical emergency.
15. Hypertension in Pregnancy
Classification
-
Chronic hypertension
- Present before pregnancy or diagnosed before 20 weeks gestation.
- Also includes hypertension that persists beyond 12 weeks postpartum.
-
Gestational hypertension
- New hypertension after 20 weeks gestation.
- No proteinuria or features of maternal organ dysfunction.
-
Preeclampsia
- New hypertension after 20 weeks with proteinuria and/or maternal organ dysfunction.
-
Eclampsia
- Preeclampsia with seizures.
-
Chronic hypertension with superimposed preeclampsia
- Worsening hypertension with new proteinuria or maternal organ dysfunction.
Hypertensive disorders of pregnancy include chronic HTN, gestational HTN, preeclampsia/eclampsia, and preeclampsia superimposed on chronic HTN. Goldman-Cecil Medicine, 2-volume set.
Preeclampsia
Diagnosis
New-onset hypertension after 20 weeks:
- BP ≥140/90 mmHg on two occasions
Plus either:
- Proteinuria, or
- Maternal organ dysfunction, such as thrombocytopenia, renal impairment, elevated liver enzymes, pulmonary edema, persistent neurologic symptoms, or visual disturbance.
Severe features
- BP ≥160/110 mmHg
- Severe headache, visual symptoms
- Epigastric/right upper quadrant pain
- Pulmonary edema
- Thrombocytopenia
- Elevated liver enzymes
- Renal impairment
- Fetal growth restriction
Drugs safe in pregnancy
- Labetalol
- Nifedipine
- Methyldopa
- Hydralazine, especially IV in severe hypertension
Contraindicated in pregnancy
- ACE inhibitors
- ARBs
- Direct renin inhibitors
Eclampsia treatment
- Stabilize airway, breathing, circulation.
- Magnesium sulfate for seizure prevention/treatment.
- Control severe BP.
- Definitive treatment is delivery after maternal stabilization, depending on gestation and maternal-fetal status.
16. Short Exam Answers
Define resistant hypertension.
BP above target despite use of three antihypertensive drugs of different classes at optimal or maximally tolerated doses, ideally including a diuretic, or controlled BP requiring four or more drugs.
What is white-coat hypertension?
Elevated clinic BP with normal out-of-office BP on ABPM/HBPM.
What is masked hypertension?
Normal clinic BP but elevated out-of-office BP.
What is isolated systolic hypertension?
Systolic BP ≥140 mmHg with diastolic BP <90 mmHg, usually due to arterial stiffness in elderly people.
What is hypertensive emergency?
Severe BP elevation with acute target-organ damage requiring monitored IV antihypertensive treatment.
What are the main first-line drugs?
- Thiazide/thiazide-like diuretic
- ACE inhibitor
- ARB
- Calcium-channel blocker
17. One-Minute Revision
- Confirm hypertension with repeated readings and preferably HBPM/ABPM.
- Essential HTN is the commonest type.
- Suspect secondary HTN in young onset, abrupt worsening, resistant HTN, hypokalemia, renal disease, or episodic symptoms.
- Assess heart, brain, kidneys, retina, and vessels for target-organ damage.
- Lifestyle therapy is for all patients.
- First-line drugs: thiazide-like diuretic, ACEi, ARB, CCB.
- Preferred combination: ACEi/ARB + CCB or thiazide-like diuretic.
- Do not combine ACEi + ARB.
- Hypertensive emergency means severe BP plus acute target-organ damage.
- In emergency, lower MAP by no more than 20%-25% in the first hour, except condition-specific situations such as aortic dissection.
- Pregnancy-safe drugs: labetalol, nifedipine, methyldopa. Avoid ACEi and ARBs.